IL6 and COVID-19: Dramatically, over 50% of COVID-19 patients needed respiratory support due to an excessive pro-inflammatory response, with a massive release of interleukins (IL)-1β, IL-6 and Tumor Necrosis Factor (TNF)-α, chemokines (13) and anti-inflammatory cytokines (1).